Sanofi makes second run for EU-GMP recognition

Sanofi makes second run for EU-GMP recognition

Amid ongoing revision of the regulation of drug tenders at public hospitals, multinational corporations are renewing efforts to have EU-GMP standards for their manufacturing sites acknowledged in Vietnam to qualify for the most lucrative tenders.
GlaxoSmithKline seeking to validate EU-GMP standards

GlaxoSmithKline seeking to validate EU-GMP standards

Multinational corporations are rushing to seek official quality standards recognition in order to gain advantages and high profit in tenders of high-cost branded drugs in the lucrative Vietnamese market, but the journey will not be a fruitful one for all.